Suppr超能文献

乳腺癌中的激素受体、人表皮生长因子受体2/神经表皮生长因子受体(Her-2/Neu)及染色体畸变

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer.

作者信息

Dutta V, Chopra G S, Sahai K, Nema S K

机构信息

Classified Specialist (Pathology and Oncopathology), Army Hospital Research & Referral, Delhi Cantt.

Brigadier i/c Administration, Armed Forces Medical College, Pune-40.

出版信息

Med J Armed Forces India. 2008 Jan;64(1):11-5. doi: 10.1016/S0377-1237(08)80137-2. Epub 2011 Jul 21.

Abstract

BACKGROUND

There is a great deal of disparity in the incidence of breast cancer in rural and urban India on one hand and between India and Western population on the other.

METHODS

We analysed steroid receptor status in cases of breast cancer in a small sample of patients in armed forces. Infiltrating duct carcinomas of breast recorded histologically in mastectomy specimens in last two years were accessioned in the present study with reference to patient and tumour characteristics.

RESULT

In contrast to the higher rates reported in western literature, only 33 % of the tumours expressed estrogen receptors (ER) and progesterone receptors (PR), of which 24% were ER positive and 30% PR positive. Negative steroid receptor status did not correlate with presence or absence of metastatic nodes, however it was predominant amongst the high grade infiltrating duct carcinomas in this study. Necrosis and lymphovascular invasion demonstrated an inverse relationship with the ER/ PR reactivity. 70% of the node positive cases expressed Her -2/ Neu, reflecting a higher immunoreactivity in this subset of patients. Aneusomy for chromosomes 1, 11 and 17 was common in node positive cases.

CONCLUSION

Evaluation of chromosomal aberrations by Fluorescent In Situ Hybridization (FISH) technique correlates well with traditional histological parameters.

摘要

背景

一方面,印度农村和城市乳腺癌发病率存在很大差异;另一方面,印度与西方人群之间也存在差异。

方法

我们分析了一小部分军队患者乳腺癌病例中的类固醇受体状态。参考患者和肿瘤特征,将过去两年在乳房切除标本中组织学记录的乳腺浸润性导管癌纳入本研究。

结果

与西方文献报道的较高比例相反,只有33%的肿瘤表达雌激素受体(ER)和孕激素受体(PR),其中24%为ER阳性,30%为PR阳性。类固醇受体阴性状态与转移淋巴结的有无无关,然而在本研究中,它在高级别浸润性导管癌中占主导。坏死和淋巴管浸润与ER/PR反应性呈负相关。70%的淋巴结阳性病例表达Her-2/Neu,反映出该亚组患者的免疫反应性较高。1、11和17号染色体的非整倍体在淋巴结阳性病例中很常见。

结论

通过荧光原位杂交(FISH)技术评估染色体畸变与传统组织学参数密切相关。

相似文献

本文引用的文献

1
HER2 or not HER2: that is the question.是HER2还是非HER2:这是个问题。
J Clin Oncol. 2005 Jun 1;23(16):3656-9. doi: 10.1200/JCO.2005.10.910. Epub 2005 Feb 28.
6
Morphologic spectrum of estrogen receptor-negative breast carcinoma.雌激素受体阴性乳腺癌的形态学谱
Arch Pathol Lab Med. 2002 Mar;126(3):325-30. doi: 10.5858/2002-126-0325-MSOERN.
7
The Indian scene.印度的情况。
J Clin Oncol. 2001 Sep 15;19(18 Suppl):106S-111S.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验